Skip to content
1932

Epidemiology

All about cholesterol

The latest science on how blood levels of HDL, LDL and more relate to cardiovascular health

Soda taxes can’t reverse the obesity epidemic

OPINION: They might be able to help, but only if well-designed and in combination with other policies

We urgently need data for equitable personalized medicine

OPINION: A massive bias in medical studies toward men of European origin means that genetic variants in understudied populations don’t get the focus they deserve

Genes and heart disease: Finally making the link

Polygenic risk scores — a patient’s chance, based on tiny DNA variants, of developing cardiovascular disease, breast cancer and more — are coming to clinics. But there are kinks to iron out and accuracy remains an issue.

The remaining frontiers in fighting hepatitis C

A scientist whose work was key to identifying, studying and finding treatments for this life-threatening virus discusses the scientific journey and challenges that persist

New views of a cough: From TB and chronic cough to hope for Parkinson’s

Scientists are revealing new secrets of the reflex that protects our lungs, spreads disease and irritates us all

What next-gen Covid-19 vaccines might look like

From building up defenses in the nose to slowing down a virus’s ability to make copies of itself, scientists are rolling out a raft of creative approaches to fighting infection

She saw the obesity epidemic coming. Then an unexpected finding mired her in controversy.

Katherine Flegal was a scientist who found herself crunching numbers for the government, until one day her analyses set off a firestorm. What does she make of her decades as a woman in public health research?

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error